**Advances in Knowledge**

1.  \- *Changing from a sitting to a supine position might affect the upper airway, possibly explaining the symptoms seen in patients with obstructive sleep apnoea syndrome such as snoring, snorting, apnoea episodes and early morning headaches*.

2.  \- *Obesity could cause lower airway obstruction in addition to upper airway occlusion during sleep*.

**Application to Patient Care**

1.  \- *Obese male patients with OSAS are at risk of having lower airway obstruction, possibly worsening their nocturnal symptoms*.

2.  \- *A change from a sitting to a supine position may cause lower airway obstruction in obese male patients with OSAS*.

Obstructive sleep apnoea syndrome (OSAS) is a growing health concern as it has been associated with a number of serious comorbidities particularly of the cardiovascular system.[@b1-squmj1911-e310-315],[@b2-squmj1911-e310-315] Sleep apnoea is defined as the cessation of airflow for a period of 10 seconds or more (apnoea) or diminished airflow accompanied by either ≥3% oxygen desaturation or awakening from sleep.[@b3-squmj1911-e310-315]

OSAS is mainly related to obesity, which is defined as a body mass index (BMI) of more than 30 kg/m^2^.[@b4-squmj1911-e310-315] As the prevalence of obesity has increased, there has been a parallel increase in the prevalence of OSAS.[@b5-squmj1911-e310-315]

The pathophysiology of OSAS is complex and not completely understood, particularly for non-obese OSAS patients. A narrowed upper airway is commonly seen in patients with OSAS and may be attributed to other factors such as fat deposition in the neck or abnormal bony morphology of the upper airway.[@b6-squmj1911-e310-315] Such defects may lead to functional impairment of the upper airway dilating muscles and alter airway diameter and transmural pressures. Even in non-obese subjects, the upper airway's diameter reduces in the supine posture.[@b7-squmj1911-e310-315] This deficit is likely to be exaggerated in patients with OSAS, particularly while the individual is supine due to the effect of gravity. Spirometry and flow-volume loops have been used to detect the presence of airway obstruction in patients with OSAS.[@b8-squmj1911-e310-315]--[@b11-squmj1911-e310-315]

Evidence suggests that overweight/obesity may also affect lung function in non-asthmatic subjects.[@b11-squmj1911-e310-315],[@b12-squmj1911-e310-315] The underlying mechanisms of these observations have not been adequately studied but it is believed to result from a complex interaction between mechanical and metabolic factors. For example, obesity affects the respiratory system by increasing the deposition of adipose tissue in the upper respiratory tract. These tissues start to produce adipokines, which are inflammatory substances, such as interleukin (IL)-1, IL-6 and tumour necrosis factor-α. These inflammatory substances stimulate mucus secretion and may cause bronchospasms, leading to small airway obstructions.[@b12-squmj1911-e310-315]

To the best of the authors' knowledge, this is the first study to use spirometry to assess the effect of change when moving from sitting to supine in patients with OSAS. The majority of previous studies focused on spirometry parameters in the erect position, yet none consider changes occurring in a supine position.

The hypothesis of the current study was that obese OSAS patients are more prone to develop lower airway obstruction compared to non-obese patients while changing position. In addition, this study examined the effect of age and gender on the degree of lower airway obstruction in OSAS patients while changing positions.

Methods
=======

This cross-sectional study was conducted at Sultan Qaboos University Hospital (SQUH), Muscat, Oman, between December 2009 and December 2010. New patients who were over the age of 18 years and had been diagnosed with severe OSAS (apnoea-hypopnoea index \>30) after one night of level-one polysomnography as per the standard criteria of the American Academy of Sleep Medicine were included in this study.[@b13-squmj1911-e310-315] All patients were OSAS treatment naïve and were non-asthmatic, non-smokers and free of chronic obstructive pulmonary disease and other cardiopulmonary diseases. Participants were not taking medication which may affect spirometry indices such as non-selective beta-blockers.

The patients reported to the pulmonary function testing laboratory, SQUH, between 10:00 and 11:00 AM to avoid time-related variation in spirometry parameters and had been asked to refrain from consuming caffeinated drinks on the day of the test.

Height and weight were measured at the time of arrival and BMI was calculated for all subjects. Subjects with a BMI of 18.5--25 were considered non-obese, while those with a BMI of 25--30 were classified as overweight; obese subjects were classed as having a BMI \>30.[@b4-squmj1911-e310-315] Participants were then split into two groups: obese (BMI \>30) and non-obese (BMI = 18.5--30).

The spirometry device used (CPFS/D USB^™^ spirometer, MGC Diagnostics, Saint Paul, Minnesota, USA) measures and calculates forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), FEV1/FVC and flow-volume curve parameters, forced expiratory flow (25--75% and at 50%; FEF), maximum forced inspiratory flow (FIFmax) and expiratory reserve volume (ERV) percentage. The spirometer used the software BreezeSuite, Version 8.5 (Medical Graphics Corporation, St. Paul, Minnesota, USA).

A three-litre calibration syringe was used to provide the calibration signal. Room temperature, relative humidity and barometric pressure were entered into the spirometer prior to starting the procedure. The device reported all values at body temperature and pressure saturated with water vapour. Spirometry was performed based on the standards and guidelines of the American Thoracic Society.[@b14-squmj1911-e310-315]

The subjects breathed 5--6 times at tidal volume and then breathed in maximally and breathed out maximally to residual volume. The procedure was done while patients were supine and while they were sitting. A new pneumotach and nose clip were used for each patient to avoid contamination through saliva or body fluids.

All participants performed the slow vital capacity (SVC) and FVC manoeuvers thrice while sitting and thrice while supine. Three minutes were given between each FVC trial. The best effort in each posture was included for the analysis.

The data were analysed using Statistical Package for the Social Sciences (SPSS), Version 23 (IBM Corp., Armonk, New York, USA). Normality of the parameters under study was checked using a Kolmogorov-Smirnov one sample test; if the distribution pattern was normal, then an independent samples t-test was used to evaluate the significance of the difference between the means of the two groups. If the distribution pattern was not normal, then the non-parametric Mann-Whitney-U test was used to determine the equality of the two groups. A *P* value of ≤0.05 was considered statistically significant.

Changes in spirometry parameters were calculated using the following formula:
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The mean difference in change of position from sitting and supine positions was compared based on BMI, age and gender.

Informed consent was obtained from all participants and the study was explained. Participants could withdraw from the study at any time. The study was approved by the Medical Research & Ethics Committee of the College of Medicine & Health Sciences, SQUH (MREC \#488).

Results
=======

A total of 27 OSAS patients were included in this study, the majority of which were male (70.4%). The mean male patient age was 40.32 ± 9.68 years, the mean male BMI was 32.11 ± 4.83 kg/m^2^ and the mean male apnoea/hypopnoea index was 49.01 ± 23.78. The mean female patient age was 47.63 ± 7.21 years, the mean female BMI was 37.26 ± 4.55 kg/m^2^ and the mean female apnoea/hypopnoea index was 53.05 ± 18.31. There was a significant difference in BMI (*P* = 0.02) but not age (*P* = 0.07) or apnoea/hypopnoea index (*P* = 0.67) between the genders. The mean patient age was 41.82 ± 9.69 years and mean BMI was 33.68 ± 5.44 kg/m^2^.

There was no significant difference in FVC or FEV1 between non-obese and obese OSAS patients in sitting and supine positions or when changing posture from a sitting to a supine position. However, there was a significant difference in the change of FEV1/FVC between obese and non-obese subjects (−0.81% versus 1.58%; *P* = 0.030). There was no significant difference in the remaining parameters with change of posture or with absolute values \[[Tables 1](#t1-squmj1911-e310-315){ref-type="table"} and [2](#t2-squmj1911-e310-315){ref-type="table"}\].

There was a significant difference between the patients who were ≤40 years old and \>40 years old in all absolute values of the spirometry parameters in sitting and supine positions (*P* \<0.05) except FEV1/FVC and FIFmax (*P* \>0.05). There was no significant difference between the two groups when changing posture in any of the spirometry parameters (*P* \>0.05) \[[Tables 3](#t3-squmj1911-e310-315){ref-type="table"} and [4](#t4-squmj1911-e310-315){ref-type="table"}\].

There was a significant difference between gender in all absolute values of the spirometry parameters (*P* \<0.05) except FEV1/FVC in the supine position, FEF 25--75% in the supine position and FIFmax in a supine position (*P* \>0.05). There was a significant difference between male and female participants in the change of FVC while changing position from a sitting to supine (5.66 ± 3.65 versus 2.66 ± 2.95; *P* = 0.050). Other parameters did not show any significant differences between genders with change of position \[[Tables 5](#t5-squmj1911-e310-315){ref-type="table"} and [6](#t6-squmj1911-e310-315){ref-type="table"}\].

Discussion
==========

Spirometry and flow-volume loops are simple, commonly used tests in patients with respiratory diseases. This study aimed to examine the effect of a change of position on the reactivity of airways in OSAS patients with different risk factors such as obesity, age and gender.

No significant difference was found in FEV1/FVC when changing from sitting to supine positions between obese and non-obese OSAS patients. This finding can be attributed to a greater reduction of FVC in obese subjects. Nevertheless, no significant difference was found between the two groups with absolute values of spirometry parameters in either position. This finding would support the initial assumption that obesity may predispose individuals with OSAS to an obstructive airway pattern when moving from a sitting to supine position. This may be due to the limited mobility of the diaphragm and chest wall when in a supine position.[@b15-squmj1911-e310-315] The current study contradicts Hoffstein *et al*.'s findings that sleep apnoea is unrelated to pulmonary function measured during wakefulness.[@b16-squmj1911-e310-315] However, Hoffstein *et al*. studied a larger cohort compared to the current sample size and measured the spirometry parameters in one position only while the current study examined the difference resulting from a change in position.[@b16-squmj1911-e310-315]

In the current study, a significant difference was found in absolute values for most of the spirometry parameters in both positions when comparing OSAS patients who were less than or more than 40 years old. This finding may be attributed to the effect of age on lung functions. However, no significant changes were found in the mean differences of those parameters between the two groups. Previous studies have indicated, that with age, all spirometry parameters decrease which could be attributed to a decrease in elastic recoil and stiffening of the chest wall.[@b17-squmj1911-e310-315] This decline, however, mostly occurs after the age of 60 according to Medbø and Melbye.[@b18-squmj1911-e310-315] Other explanations for this finding could be that aging does not cause lower airway obstruction while changing position. Further studies are required to confirm this phenomenon.

An additional risk factor for OSAS is being male.[@b19-squmj1911-e310-315] In the current study there was a weak significant difference of the percentage decrease in FVC when comparing male and female patients with no significant increase in FEV1/FVC. Males have been found to be more prone to develop severe OSAS due to anatomical factors and impaired ventilatory control during sleep.[@b19-squmj1911-e310-315] In addition, men have a greater abdominal fat distribution than women, which may explain less frequent FVC and FEV1.[@b15-squmj1911-e310-315]

When comparing OSAS patients in different positions, significant differences were found between different factors. Campbell *et al*. compared OSAS patients and patients with brief upper airway dysfunction (BUAD) with normal subjects and found no difference in flow-volume curve indices.[@b20-squmj1911-e310-315] However, they eliminated the confounders of obesity and age which were the main variables under comparison in the current study. Nevertheless, Campbell *et al*.'s study measured the flow-volume curve in different positions as did the current study. Campbell *et al*.'s main aim was to predict OSAS and BUAD from changes in flow-volume curve which differs from the current study which examines the relationship between changes in spirometry parameters and changes in posture in patients with severe OSAS.

The current study has limitations. A major limitation is the study's small sample size which might have affected the statistical reliability of the comparisons. Additionally, OSAS patients were not compared with non-OSAS subjects. However, it is extremely difficult to find obese subjects without OSAS. Obesity was measured in only one way and should have been measured by different means such as waist/hip ratio and neck circumference in order to determine whether the patient is truly obese. For example, patients with high muscle mass can have a high BMI but not be obese. While the current study examined the spirometry indices of patients with OSAS in two positions, adding a standing position in future studies would add more value to this type of examination.

Conclusion
==========

A supine position may increase lower airway obstruction in obese patients with OSAS. However, in patients with OSAS, age and, to a lesser extent, gender did not have a large impact on spirometry parameters while changing between sitting and supine positions.
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###### 

Comparison of mean spirometry parameters between obese and non-obese obstructive sleep apnoea syndrome patients while changing from a sitting to supine position (N = 27)

  Spirometry parameter in percentage   Mean ± SD       *P* value       
  ------------------------------------ --------------- --------------- -------
  FVC                                  6.42 ± 4.7      3.95 ± 2.85     0.100
  FEV1                                 5.87 ± 3.43     5.48 ± 2.7      0.750
  FEV1/FVC                             −0.81 ± 1.88    1.58 ± 1.72     0.030
  FEF 25--75%                          20.54 ± 11.61   21.03 ± 9.09    0.910
  FEF 50%                              13.35 ± 13.27   13.86 ± 11.08   0.920
  FIFmax                               11.8 ± 24.11    5.65 ± 12.36    0.489
  ERV                                  26.79 ± 48.23   25.68 ± 49.03   0.956

SD = standard deviation; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; FEF = forced expiratory flow; FIFmax = maximum forced inspiratory flow; ERV = expiratory reserve volume.

###### 

Comparison of absolute values of spirometry parameters between obese and non-obese obstructive sleep apnoea syndrome patients in sitting and supine positions (N = 27)

  Spirometry parameter in litre (position)   Mean ± SD        *P* value        
  ------------------------------------------ ---------------- ---------------- -------
  FVC (sitting)                              3.424 ± 0.817    3.187 ± 1.165    0.590
  FVC (supine)                               3.214 ± 0.839    3.058 ± 1.113    0.714
  FEV1 (sitting)                             2.883 ± 0.700    2.710 ± 0.899    0.618
  FEV1 (supine)                              2.718 ± 0.690    2.562 ± 0.855    0.640
  FEV1/FVC (sitting)                         84.111 ± 4.755   86.222 ± 4.697   0.283
  FEV1/FVC in % (supine)                     84.778 ± 4.755   84.833 ± 4.274   0.976
  FEF 25--75% (sitting)                      3.361 ± 1.042    3.322 ± 1.028    0.927
  FEF 25--75% (supine)                       2.677 ± 0.914    2.629 ± 0.882    0.897
  FEF 50% (sitting)                          4.144 ± 1.199    4.189 ± 1.235    0.932
  FEF 50% (supine)                           3.574 ± 1.095    3.597 ± 1.191    0.963
  FIFmax (sitting)                           4.933 ± 1.772    4.605 ± 1.742    0.650
  FIFmax (supine)                            4.162 ± 1.444    4.314 ± 1.544    0.807
  ERV (sitting)                              0.664 ± 0.312    0.545 ± 0.408    0.448
  ERV (supine)                               0.419 ± 0.251    0.359 ± 0.319    0.627

SD = standard deviation; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; FEF = forced expiratory flow; FIFmax = maximum forced inspiratory flow; ERV = expiratory reserve volume.

###### 

Comparison of absolute values of spirometry parameters between patients less than and more than 40 years old when changing from sitting to supine position (N = 27)

  Spirometry parameter in litre (position)   Mean ± SD        *P* value        
  ------------------------------------------ ---------------- ---------------- -------
  FVC (sitting)                              3.916 ± 0.947    2.819 ± 0.892    0.005
  FVC (supine)                               3.716 ± 0.965    2.694 ± 0.845    0.007
  FEV1 (sitting)                             3.340 ± 0.710    2.374 ± 0.670    0.001
  FEV1 (supine)                              3.133 ± 0.715    2.258 ± 0.647    0.003
  FEV1/FVC in % (sitting)                    85.909 ± 4.437   85.250 ± 5.053   0.730
  FEV1/FVC in % (supine)                     85.000 ± 4.450   84.688 ± 4.438   0.859
  FEF 25--75% (sitting)                      4.065 ± 1.022    2.833 ± 0.650    0.001
  FEF 25--75% (supine)                       3.191 ± 0.981    2.269 ± 0.564    0.005
  FEF 50% (sitting)                          4.751 ± 1.083    3.753 ± 1.132    0.033
  FEF 50% (supine)                           4.154 ± 1.209    3.176 ± 0.919    0.028
  FIFmax (sitting)                           5.015 ± 1.438    4.508 ± 1.915    0.464
  FIFmax (supine)                            4.729 ± 1.451    3.944 ± 1.466    0.182
  ERV (sitting)                              0.805 ± 0.380    0.434 ± 0.300    0.009
  ERV (supine)                               0.548 ± 0.350    0.263 ± 0.182    0.026

SD = standard deviation; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; FEF = forced expiratory flow; FIFmax = maximum forced inspiratory flow; ERV = expiratory reserve volume.

###### 

Comparison of mean spirometry parameters between patients less than and more than 40 years old when changing from sitting to supine position (N = 27)

  Spirometry parameter in percentage   Mean ± SD       *P* value       
  ------------------------------------ --------------- --------------- -------
  FVC                                  5.35 ± 4.50     4.37 ± 3.09     0.504
  FEV1                                 6.44 ± 3.22     5.04 ± 2.62     0.225
  FEV1/FVC                             1.04 ± 2.15     0.60 ± 2.09     0.600
  FEF 25--75%                          22.02 ± 10.04   20.06 ± 9.84    0.619
  FEF 50%                              12.94 ± 10.94   14.27 ± 12.29   0.778
  FIFmax                               6.51 ± 12.16    8.51 ± 19.95    0.770
  ERV                                  34.90 ± 26.58   19.96 ± 58.29   0.378

SD = standard deviation; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; FEF = forced expiratory flow; FIFmax = maximum forced inspiratory flow; ERV = expiratory reserve volume.

###### 

Comparison of absolute values of spirometry parameters between male and female obstructive sleep apnoea syndrome patients in sitting and supine positions (N = 27)

  Spirometry parameter in litre (position)   Mean ± SD        *P* value        
  ------------------------------------------ ---------------- ---------------- ---------
  FVC (sitting)                              3.689 ± 0.915    2.261 ± 0.562    \<0.001
  FVC (supine)                               3.490 ± 0.918    2.209 ± 0.588    0.001
  FEV1 (sitting)                             3.096 ± 0.724    1.988 ± 0.460    0.001
  FEV1 (supine)                              2.915 ± 0.710    1.900 ± 0.463    0.001
  FEV1/FVC in % (sitting)                    84.316 ± 4.820   88.375 ± 3.204   0.039
  FEV1/FVC in % (supine)                     84.000 ± 4.333   86.750 ± 3.204   0.137
  FEF 25--75% (sitting)                      3.585 ± 1.077    2.743 ± 0.510    0.046
  FEF 25--75% (supine)                       2.836 ± 0.924    2.191 ± 0.562    0.080
  FEF 50% (sitting)                          4.528 ± 1.207    3.380 ± 0.750    0.021
  FEF 50% (supine)                           3.912 ± 1.197    2.864 ± 0.541    0.027
  FIFmax (sitting)                           5.232 ± 1.725    3.486 ± 0.975    0.013
  FIFmax (supine)                            4.595 ± 1.530    3.476 ± 1.080    0.073
  ERV (sitting)                              0.733 ± 0.349    0.232 ± 0.107    \<0.001
  ERV (supine)                               0.456 ± 0.314    0.195 ± 0.119    0.004

SD = standard deviation; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; FEF = forced expiratory flow; FIFmax = maximum forced inspiratory flow; ERV = expiratory reserve volume.

###### 

Comparison of mean spirometry parameters between male and female obstructive sleep apnoea syndrome patients when changing from a sitting to supine position (N = 27)

  Spirometry parameter in percentage   Mean ± SD       *P* value        
  ------------------------------------ --------------- ---------------- -------
  FVC                                  5.66 ± 3.65     2.66 ± 2.95      0.050
  FEV1                                 6.03 ± 2.93     4.61 ± 2.74      0.254
  FEV1/FVC                             0.32 ± 2.21     1.87 ± 1.63      0.077
  FEF 25--75%                          20.99 ± 9.78    20.553 ± 10.43   0.917
  FEF 50%                              13.66 ± 11.07   13.79 ± 13.31    0.979
  FIFmax                               10.66 ± 18.32   0.652 ± 11.13    0.166
  ERV                                  30.22 ± 52.31   16.14 ± 36.07    0.496

SD = standard deviation; FVC = forced vital capacity; FEV1 = forced expiratory volume in the first second; FEF = forced expiratory flow; FIFmax = maximum forced inspiratory flow; ERV = expiratory reserve volume.
